FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Rydex Biotechnology Fund Class Investor Stock AnalysisComprehensive stock analysis for Rydex Biotechnology Fund Class Investor (RYOIX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRYOIX
RYOIX
Rydex Biotechnology Fund Class Investor
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RYOIX
Home🔹Stocks🔹Rydex Biotechnology Fund Class Investor

Rydex Biotechnology Fund Class Investor

RYOIX•NASDAQ

Rydex Biotechnology Fund Class Investor

RYOIX•NASDAQ
Market cap
$92.80M
Sentiment

Your view on RYOIX

Mkt Cap
$92.80M
Sentiment
Your view
RYOIX
Rydex Biotechnology Fund Class Investor
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RYOIX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Rydex Biotechnology Fund Class Investor

Industry
Asset Management
Sector
Financial Services
CEO
Not available
Headquarters
702 King Farm Boulevard, Rockville, MD, US
Industry
Asset Management
Sector
Financial Services
CEO
Not available
Headquarters
702 King Farm Boulevard, Rockville, MD, US
Description

The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News